A tumor stem cell marker DCLK1 promotes hepatocellular carcinoma by regulating β-catenin, EMT and clonogenic properties of hepatocytes

被引：0
|
作者：
Ali, Naushad
Nguyen, Charles B.
Chandrakesan, Parthasarathy
May, Randal
Dhanasekaran, Danny
Bronze, Michael S.
Houchen, Courtney W.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-3884
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3884
引用
收藏
页数：2
相关论文
共 50 条
  • [41] TMPRSS4 promotes cancer stem cell traits by regulating CLDN1 in hepatocellular carcinoma
    Mahati, Shaya
    Bolati, Dilinaer
    Yang, Ying
    Mao, Rui
    Zhang, Hua
    Bao, YongXing
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 490 (03) : 906 - 912
  • [42] Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients
    Mirzaei, Alireza
    Tavoosidana, Gholamreza
    Modarressi, Mohammad Hossein
    Rad, Afshin Abdi
    Fazeli, Mohammad Sadegh
    Shirkoohi, Reza
    Tavakoli-Yaraki, Masoumeh
    Madjd, Zahra
    TUMOR BIOLOGY, 2015, 36 (06) : 4801 - 4810
  • [43] AURKA promotes cancer metastasis by regulating epithelial-mesenchymal transition and cancer stem cell properties in hepatocellular carcinoma
    Chen, Chenlin
    Song, Guangyuan
    Xiang, Jue
    Zhang, Hongcheng
    Zhao, Shaoyun
    Zhan, Yinchu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 486 (02) : 514 - 520
  • [44] Lycorine promotes cell senescence of hepatocellular carcinoma by regulating CDK1.
    Yu, Haiyang
    Yin, Shuangshuang
    Qiu, Yuling
    Luo, Yanming
    Hu, Gaoyong
    Lu, Jia
    Zhou, Shiyue
    Wang, Tao
    CANCER RESEARCH, 2021, 81 (13)
  • [45] LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis
    Zhang, Y. -T.
    Li, B. -P.
    Zhang, B.
    Ma, P.
    Wu, O-L.
    Ming, L.
    Xie, L. -M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (19) : 6333 - 6341
  • [46] Regulation of miRNAs by Agents Targeting the Tumor Stem Cell Markers DCLK1, MSI1, LGR5, and BMI1
    Sureban S.M.
    Qu D.
    Houchen C.W.
    Current Pharmacology Reports, 2015, 1 (4) : 217 - 222
  • [47] The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer (vol 9, pg 346, 2014)
    Vedeld, Hege Marie
    Skotheim, Rolf I.
    Lothe, Ragnhild A.
    Lind, Guro E.
    EPIGENETICS, 2016, 11 (08) : 635 - 635
  • [48] PAF enhances cancer stem cell properties via β-catenin signaling in hepatocellular carcinoma
    Li, Mei
    Mu, Xu-Dong
    Song, Juan-Rong
    Zhai, Peng-Tao
    Cheng, Yuan
    Le, Yao
    Li, Zhu-Bin
    CELL CYCLE, 2021, 20 (10) : 1010 - 1020
  • [49] GSG2 promotes tumor growth through regulating cell proliferation in hepatocellular carcinoma
    Li, Luhao
    Li, Suxin
    Wang, Haohao
    Li, Lin
    Wang, Peiju
    Shen, Dongqi
    Dang, Xiaowei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 625 : 109 - 115
  • [50] Progastrin Up-Regulates the Expression of Both Long and Short Isoforms of Cancer Stem Cell Marker, DCLK1, by Transcriptionally Activating Their Respective Promoters: Role of β-Catenin and NfκB Response Elements
    Sarkar, Shubhashish
    O'Connell, Malaney R.
    Luthra, Gurinder
    Singh, Pomila
    GASTROENTEROLOGY, 2014, 146 (05) : S516 - S516
12345